The OPTIC study: Patient views on optimising immunotherapy in cancer

UCL Minds

Optimisation immunotherapy clinical trials investigate ways of reducing the intensity of immunotherapy cancer treatment. This could be beneficial for patients’ quality of life. But these trials can be challenging to run, as patients may be concerned about the impact that reducing the intensity of treatment could have on the cancer. This episode of the Trial Talk podcast focuses on the MRC Clinical Trials Unit at UCL’s OPTIC study, which explores how people with cancer feel about taking part in optimisation immunotherapy trials. Clinical Fellow Sophie Merrick discusses the main barriers that patients face and recommendations to address them. Resources: •OPTIC study page: www.mrcctu.ucl.ac.uk/studies/all-st…/refine/optic/ •OPTIC results paper: www.nature.com/articles/s41416-024-02756-x.pdf •REFINE podcast episode: on.soundcloud.com/Fe3C76csHkgCg2or5 For questions or feedback on the series, message us at [e-mail] For more information and to access the transcript: bit.ly/4c9SfAr As a listener, your opinion is very valuable to us. Please help us to improve the podcast in future by filling in this short survey: forms.office.com/e/PjfjQ5Mn6g Date of episode recording: 2024-06-18T00:00:00Z Duration: 00:25:23 Language of episode: English Presenter: Berta Terre-Torras Guests: Sophie Merrick Producer: Berta Terre-Torras